Phase 2 Acute Promyelocytic Leukemia Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia With PML-RARA
M.D. Anderson Cancer Center151 enrolled5 locationsNCT01409161
Recruiting
Phase 2
Frontline Oral Arsenic Trioxide for APL
Acute Promyelocytic Leukemia
The University of Hong Kong100 enrolled2 locationsNCT04687176
Recruiting
Phase 2
Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia (APL)
Instituto do Cancer do Estado de São Paulo115 enrolled1 locationNCT06982274
Recruiting
Phase 2
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica89 enrolled31 locationsNCT04793919